BioVie Inc.
BIVI
$1.71
-$0.04-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.11% | -19.67% | 12.29% | 6.78% | 2.26% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.53% | -61.35% | -16.95% | -62.10% | -56.36% |
| Operating Income | 23.53% | 61.35% | 16.95% | 62.10% | 56.36% |
| Income Before Tax | 29.38% | 65.44% | 15.34% | 61.23% | 45.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.38% | 65.44% | 15.34% | 61.23% | 45.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.38% | 65.44% | 15.34% | 61.23% | 45.78% |
| EBIT | 23.53% | 61.35% | 16.95% | 62.10% | 56.36% |
| EBITDA | 23.82% | 61.81% | 17.06% | 62.43% | 56.66% |
| EPS Basic | 76.77% | 92.46% | 79.31% | 76.01% | 67.82% |
| Normalized Basic EPS | 76.77% | 91.63% | 79.44% | 77.75% | 67.82% |
| EPS Diluted | 76.77% | 92.47% | 79.10% | 76.03% | 67.82% |
| Normalized Diluted EPS | 76.77% | 91.63% | 79.44% | 77.75% | 67.82% |
| Average Basic Shares Outstanding | 204.01% | 313.10% | 311.76% | 74.24% | 68.50% |
| Average Diluted Shares Outstanding | 204.01% | 313.10% | 311.76% | 74.24% | 68.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |